Antagonistic effect of kanamycin on kanamycin-resistant Escherichia coli infection by BtuB-targeting bacteriophages
Archives of Virology · 2025
DOI: 10.1007/s00705-025-06358-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, 2025. Verfasst von Yewon Jung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Animal Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Republic o…. Hauptthemen laut MEDLINE: Kanamycin, Escherichia coli, Anti-Bacterial Agents, Escherichia coli Proteins. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
In combined treatments with antibiotics and bacteriophages (phages), antibiotics have the potential to influence phage infectivity, exhibiting effects that vary from synergistic to antagonistic. Here, we investigated the effects of various classes of antibiotics on Escherichia coli infection by phages that use different receptors, including vitamin B12 outer membrane transporter (BtuB), lipopolysaccharide (LPS), outer membrane protein A (OmpA), and nucleoside-specific porin (Tsx). Among the antibiotics tested, ampicillin did not affect phage infection, whereas colistin, chloramphenicol, and tetracycline inhibited phage infection irrespective of the phage receptor. In contrast, kanamycin inhibited infection of kanamycin-resistant E. coli by the BtuB-targeting phages, but not by the phages using LPS, OmpA, or Tsx. The receptor-specific antagonistic effect of kanamycin on BtuB-targeting phage infection was stronger than the effect observed with colistin, chloramphenicol, or tetracycline. When using a btuB-knockout mutant, we observed reduced kanamycin accumulation and increased kanamycin resistance compared to wild-type E. coli, suggesting that BtuB might be involved in kanamycin uptake. These results suggest that the antagonism between kanamycin and BtuB-targeting phage infection may be linked to the role of BtuB in facilitating kanamycin uptake. This study shows that the antimicrobial activity of phage-antibiotic combinations may be phage-receptor-specific, highlighting the need to consider phage receptors when selecting optimal combinations for effective phage therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Food and Animal Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
- Department of Agricultural Biotechnology, Seoul National University, Seoul, 08826, Republic of Korea.
- Center for Food Bioconvergence, Seoul National University, Seoul, 08826, Republic of Korea.
- Department of Food Science & Biotechnology, and Carbohydrate Bioproduct Research Center, Sejong University, Seoul, 05006, Republic of Korea.
- Department of Food and Animal Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Republic of Korea. sangryu@snu.ac.kr.
- Department of Agricultural Biotechnology, Seoul National University, Seoul, 08826, Republic of Korea. sangryu@snu.ac.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jung, Y., Kim, J., & Ryu, S. (2025). Antagonistic effect of kanamycin on kanamycin-resistant Escherichia coli infection by BtuB-targeting bacteriophages. Archives of Virology. https://doi.org/10.1007/s00705-025-06358-7
Vancouver
Jung Y, Kim J, Ryu S. Antagonistic effect of kanamycin on kanamycin-resistant Escherichia coli infection by BtuB-targeting bacteriophages. Archives of Virology. 2025. doi:10.1007/s00705-025-06358-7
BibTeX
@article{Jung2025,
author = {Jung, Yewon and Kim, Jinshil and Ryu, Sangryeol},
title = {Antagonistic effect of kanamycin on kanamycin-resistant Escherichia coli infection by BtuB-targeting bacteriophages},
journal = {Archives of Virology},
year = {2025},
doi = {10.1007/s00705-025-06358-7}
}
EUVIMED